A Digital Publication for the Practicing Medical Specialist, Industry Executive & Investor

HomeTagsHydrus Microstent

Hydrus Microstent

1st Patient Enrolled in Pivotal Clinical Trial Evaluating the Hydrus Microstent in Standalone MIGS for Mild to Moderate Glaucoma

The FRONTIER trial will build on long-term findings from the Hydrus HORIZON five-year pivotal trial, which showed a 47% reduction in visual field loss, sustained reduction in medication use, and over 60% reduction in subsequent, more invasive glaucoma surgery.
Spot_ImgSpot_Img

By using this website you agree to accept Medical Device News Magazine Privacy Policy